AI vs Bureaucracy: Reinventing National Security Compliance from the Ground Up | Andrew Black - CEO, Kovr.ai

Episode notes

Send us Fan Mail Most people assume national security delays are about technology. They’re not. They’re about paperwork - and it can take up to two years just to deploy software the government already wants. Andrew Black is a national security entrepreneur, cybersecurity executive, and emerging technology strategist whose career has sat at the intersection of AI, defense, cyber risk, and global security operations. Andrew is currently the CEO of Kovr.ai ( ) an AI-native cyber compliance platform focused on one of the biggest bottlenecks in modern national security: getting software and cloud systems authorized for use in highly regulated and classified environments. Kovr.ai is using AI to automate complex compliance frameworks like FedRAMP and CMMC, helping organizations become “ATO-ready” (Authority to Operate) in minutes rather than months.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• CMMC Level 2: Documentation, Costs, and Audit Readiness | Interview with Bruno LecoqSecure & Simple · on Cybersecurity89 / 100
• Mastercard CEO: AI Shopping Agents, Machine-to-Machine Payments, and the New Infrastructure of CommerceMotley Fool Hidden Gems Investing · on Cybersecurity88 / 100
• Navigating AI Risks with Trevor Horwitz from TrustNetB2B Automation Spotlight · on Cybersecurity79 / 100
• Moving from Product Partnerships to Revenue: Jira Cooley on Owning the NumberBetween Product and Partnerships · on Cybersecurity76 / 100
• Pipeline Gives Permission to Invest Big on Brand with Jennifer JohnsonThe B2B CMO Podcast with Jon Miller and Sydney Sloan · on Cybersecurity74 / 100
• Healthcare AI Has a Cybersecurity ProblemCareTalk: Healthcare. Unfiltered. · on Cybersecurity

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen